文献速递系统性红斑狼疮其他结缔组织病

小鼠狼疮弥漫性肺泡出血的发病机制

Pathogenesis of Diffuse Alveolar Hemorrhage in Murine Lupus.
PubMed 文献 · Arthritis Rheumatol · 2017-05-05

该研究在降植烷诱导的C57BL/6狼疮小鼠模型中探究弥漫性肺泡出血(DAH)的发病机制,发现降植烷迁移至肺引起细胞死亡、小血管炎和肺泡出血,其发生依赖天然IgM和补体调理死亡细胞及补体受体介导的肺部炎症,且为巨噬细胞依赖、IL-10保护性过程。

要点

  • DAH发病依赖天然IgM和补体对死亡细胞的调理及补体受体介导的肺部炎症。
  • 巨噬细胞活化是DAH发病核心,氯膦酸盐脂质体可预防DAH。
  • IL-10具有保护作用,补体抑制和巨噬细胞靶向治疗或可降低死亡率。

核心结论

  • DAH的发病机制涉及天然IgM和补体对死亡细胞的调理,随后由补体受体介导肺部炎症。
  • 该病为巨噬细胞依赖性疾病,IL-10具有保护作用。
  • 补体抑制和/或巨噬细胞靶向治疗可能降低狼疮相关DAH的死亡率。

研究设计与样本

  • 研究在降植烷诱导的C57BL/6小鼠狼疮模型中比较DAH的临床/病理和免疫表现与人类DAH。
  • 通过质谱法检测降植烷的组织分布。
  • 通过氯膦酸盐脂质体和抗中性粒细胞单克隆抗体(抗Ly-6G)进行体内清除以确定致病细胞类型。
  • 使用眼镜蛇毒因子(CVF)检查补体清除的效果。

主要发现

  • 腹腔注射后降植烷迁移至肺,引起细胞死亡、小血管炎和肺泡出血,类似人类DAH。
  • B细胞缺陷小鼠对DAH诱导有抵抗,但输注IgM可恢复易感性。
  • C3-/-和CD18-/-小鼠也有抵抗,CVF可预防野生型小鼠DAH。
  • DAH诱导独立于Toll样受体、炎症小体和诱导型一氧化氮。
  • IL-10缺陷小鼠死亡率增加,降植烷处理降低单核细胞IL-10受体表达和肺巨噬细胞STAT-3磷酸化。

临床怎么用

  • 补体抑制和/或巨噬细胞靶向治疗可能降低狼疮相关DAH死亡率。
  • IL-10具有保护作用,提示其通路可能为治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Diffuse alveolar hemorrhage (DAH) in lupus patients confers >50% mortality, and the cause is unknown. We undertook this study to examine the pathogenesis of DAH in C57BL/6 mice with pristane-induced lupus, a model of human lupus-associated DAH. METHODS: Clinical/pathologic and immunologic manifestations of DAH in pristane-induced lupus were compared with those of DAH in humans. Tissue distribution of pristane was examined by mass spectrometry. Cell types responsible for disease were determined by in vivo depletion using clodronate liposomes and antineutrophil monoclonal antibodies (anti-Ly-6G). The effect of complement depletion with cobra venom factor (CVF) was examined. RESULTS: After intraperitoneal injection, pristane migrated to the lung, causing cell death, small vessel vasculitis, and alveolar hemorrhage similar to that seen in DAH in humans. B cell-deficient mice were resistant to induction of DAH, but susceptibility was restored by infusing IgM. C3-/- and CD18-/- mice were also resistant, and DAH was prevented in wild-type mice by CVF. Induction of DAH was independent of Toll-like receptors, inflammasomes, and inducible nitric oxide. Mortality was increased in interleukin-10 (IL-10)-deficient mice, and pristane treatment decreased IL-10 receptor expression in monocytes and STAT-3 phosphorylation in lung macrophages. In vivo neutrophil depletion was not protective, while treatment with clodronate liposomes prevented DAH, which suggests that macrophage activation is central to DAH pathogenesis. CONCLUSION: The pathogenesis of DAH involves opsonization of dead cells by natural IgM and complement followed by complement receptor-mediated lung inflammation. The disease is macrophage dependent, and IL-10 is protective. Complement inhibition and/or macrophage-targeted therapies may reduce mortality in lupus-associated DAH.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Zhuang H, Han S, Lee PY, et al. Pathogenesis of Diffuse Alveolar Hemorrhage in Murine Lupus. Arthritis Rheumatol. 2017. PMID: 28217966. doi:10.1002/art.40077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。